For many life sciences start-ups, bringing on a GC early can be a strategic advantage. An experienced GC can help shape the company’s legal and operational foundation from day one, reducing reliance ...

PHARMAP 2026 provides the platform for a key industry conversation: how leading pharmaceutical companies are further ...

Return on Engagement (ROE) is a call to action to better capture the multifaceted value of patient engagement.

Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug in the TRPV1 antagonist class to reach the market. Licensed from fellow Japanese drugmaker ...

Researchers in the US have said that advances in therapeutics are outpacing the development of diagnostics to guide their use, due to policy gaps and payment barriers around the world. The team, from ...

Roche is paying $20 million upfront to secure rights to two degrader-antibody conjugates (DACs), developed by longtime ...

Boehringer Ingelheim has amended its partnership with Click Therapeutics on a digital therapeutic (DTx) for schizophrenia, ...

A landmark study in China has shown that a base-editing therapy developed by CorrectSequence Therapeutics achieved stellar ...

AP01 has completed a phase 1b trial (ATLAS) in idiopathic pulmonary fibrosis (IPF) and has started an open-label extension in ...

Shares in Abivax were tracking up this morning as a media report in France suggested a takeover by Eli Lilly – worth €15 billion ($17.5 billion) – could be on the cards. French newspaper La Lettre ...

At the LSX World Congress in Lisbon this year, web editor Nicole Raleigh spoke with Roi Raz, CEO of ReBio Pharma, a ...

While positive, for rare disease it represents the first step of a much longer journey – one that will determine whether ...